Jafar Panahi's latest thriller, It Was Just an Accident has an ending that will give you the chills if you watch it from the point of view of a tortured prisoner. An apt description of this movie in ...

Recursion Pharmaceuticals' AI-based approach has the potential to transform the pharmaceutical industry. However, it is still chasing clinical wins that would demonstrate the power of its strategy.

The ending of ‘Avatar: Fire and Ash’ hints at sequels, with the villain’s story left unresolved and Kiri still uncovering her connection to Eywa. ByDani Di Placido, Senior Contributor. Forbes ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

It’s time for another adventure on Pandora, as James Cameron’s Avatar series continues with the release of Avatar: Fire and Ash. The third movie in the epic sci-fi franchise follows the 2009 release ...

Recursion Pharmaceuticals (NASDAQ: RXRX) experienced an 11% increase in stock price on Wednesday after JP Morgan raised its rating, noting the promising potential of its MEK inhibitor program. However ...